The following is a list of all previous briefings for the year 2016. For briefings from other years, select from the list below.
|High-Need, High-Cost Patients: Challenges & Promising Models|
Monday, August 29, 2016
Health systems have applied many innovative new strategies for improving quality and reducing costs when it comes to care for high-need, high-cost patients, who typically have multiple chronic conditions. Which of these innovations show promise, and what can we learn from them? This briefing defines who high-need, high-cost patients are, discusses the importance of this population to health system transformation, presents current data on this population, and emphasizes the core elements of successful interventions.
|Zika Virus: Control, Monitoring, and Prevention|
Thursday, August 11, 2016
At our briefing for reporters at the National Press Club, NIH's Anthony Fauci provided an update on the state-of-play of the Zika virus in the U.S. A panel representing federal, state and local officials then discussed details of how the response will be coordinated and where resources are needed.
|Trends in Coverage and Affordability on the ACA Marketplaces|
Friday, July 15, 2016
In advance of the fourth open enrollment period for health coverage under the Affordable Care Act (ACA), which begins Nov. 1, this briefing examined who has gained coverage, who remains uninsured, and why uninsured individuals have not obtained coverage. Speakers also discussed marketplace stability, factors driving premium trends, and the outlook for 2017 premiums.
|MACRA: Stakeholder Considerations and Next Steps|
Monday, July 11, 2016
The implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) could have broad implications for physicians, health systems, health plans, consumers and others. This briefing explored the key concerns and considerations raised during the comment period, along with possibilities and prospects for moving forward.
|Briefing for Reporters on MACRA & Medicare Payments|
Thursday, June 30, 2016
This briefing reviews the requirements of MACRA, including MIPS, the APMs and the choices physicians will need to make. We also examined what this means for doctor practices and health systems who employ doctors, including what the burden of quality reporting will be for these groups, what the relative impact will be for large and small practices, and how this might accelerate or slow the trend toward provider consolidation.
|Biosimilars in the United States: Next Steps|
Monday, June 20, 2016
With biosimilar biological products moving from the lab to the marketplace, key policy and regulatory questions are being actively debated, with important implications for industry, patients, and the health care system. This discussion will provide background on current policy and regulatory issues surrounding biosimilars, and it will consider implications for the future, answering critical questions such as: What does the future of the biosimilars market hold for patients? What information do patients and their physicians need about these medicines? What role will payers play in educating health care professionals and patients?
|MACRA: New Directions for Medicare Physician Payment|
Friday, May 20, 2016
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) repealed the Sustainable Growth Rate formula (SGR) and set out a blueprint for reforming physician payment under Medicare with an eye towards better aligning Medicare payments with the cost and quality of patient care. On April 27, 2016, the Department of Health and Human Services (HHS) issued a proposed rule to implement the law. While the proposed rule provides more clarity on how to move the health care system from volume to value, questions about implementing the law remain among policymakers, providers, and patients.
|Value-Based Pricing for Prescription Drugs: Opportunities and Challenges|
Friday, April 15, 2016
Recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, or preventing a range of diseases. However, patients, providers and payers alike have raised concerns about the affordability and sustainability of these drugs. As a response to price increases of both single-source and generic drugs, some stakeholders are calling for a move towards basing payments on value, and some payers and pharmaceutical manufacturers are exploring ways to base payments on outcomes. However, many challenges remain.
|Medicare Payment System Reforms: What Do We Know? |
Monday, April 11, 2016
Medicare is testing new ways to pay for medical services, emphasizing value rather than volume, and evidence is beginning to build about successes and challenges. This briefing will examine what we know so far about the basic models, savings, quality, the impact on patients and the prospects for replication.
|Alliance for Health Reform Names Co-CEOs|
Thursday, March 24, 2016
Washington veterans Sarah Dash and Marilyn Serafini promoted from VP positions to co-lead The Alliance for Health Reform
|Briefing for Reporters on State Health Initiatives |
Friday, February 19, 2016
A governor met with reporters Friday, February 19 to discuss the latest health care innovations and changes they are pursuing or implementing. Gov. Asa Hutchinson, R-Ark., discussed his experience with the state's program to move newly eligible Medicaid beneficiaries to qualified health plans, and his intentions for changes moving forward.